World's Best Scientists 2026 revealed!
Walter E. Haefeli

Walter E. Haefeli

D-Index & Metrics

Medicine

D-Index
88
Citations
26645
World Ranking
13225
National Ranking
705

Overview

Walter E. Haefeli is affiliated with Heidelberg University in Germany and has a substantial body of work primarily in the field of Medicine. Their research encompasses several key subfields including Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, Pharmacology, Oncology, and Molecular Biology.

The main topics of Haefeli's work cover various aspects of pharmaceutical sciences and patient care. These topics include:

  • Pharmaceutical Practices and Patient Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Drug Transport and Resistance Mechanisms
  • Pharmacogenetics and Drug Metabolism
  • Pharmaceutical studies and practices
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac electrophysiology and arrhythmias

Haefeli has published extensively in several notable venues. The frequent publication venues include:

  • Pharmaceutics
  • Clinical Pharmacokinetics
  • European Journal of Clinical Pharmacology
  • Research in Social and Administrative Pharmacy
  • International Journal of Molecular Sciences

Among recent papers authored or co-authored by Haefeli are the following:

  • IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression, 2020, Cell
  • Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial, 2022, The Lancet Infectious Diseases
  • Drug-Drug Interactions with Direct Oral Anticoagulants, 2020, Clinical Pharmacokinetics
  • A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy, 2020, Leukemia
  • A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial, 2023, Alzheimer s & Dementia

Haefeli collaborates frequently with several co-authors, including:

  • Jürgen Burhenne
  • Hanna M. Seidling
  • Andreas D. Meid
  • Kathrin I. Foerster
  • Johanna Weiß

Best Publications

  • Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo

    Robinson Joannides;Walter E. Haefeli;Lilly Linder;Vincent Richard

  • IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

    Ahmed Sadik;Luis F Somarribas Patterson;Selcen Öztürk;Soumya R Mohapatra

  • Prolonged sedation due to accumulation of conjugated metabolites of midazolam

    T.M. Bauer;R. Ritz;C. Haberthür;W.E. Haefeli

  • Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

    Pavel Bogomolov;Alexander Alexandrov;Natalia Voronkova;Maria Macievich

  • Inhibition of P-Glycoprotein by Newer Antidepressants

    Johanna Weiss;Sven-Maria Gregor Dormann;Meret Martin-Facklam;Christian Johannes Kerpen

  • Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver

    Nadine Albermann;Friedrich Hubertus Schmitz-Winnenthal;Kaspar Z’graggen;Christine Volk

  • Associations of frailty with health care costs – results of the ESTHER cohort study

    Jens Oliver Bock;Hans Helmut König;Hermann Brenner;Hermann Brenner;Walter E. Haefeli

  • Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms

    Julia T. Schiele;Renate Quinzler;Hans-Dieter Klimm;Markus G. Pruszydlo

  • Modulation of human BCRP (ABCG2) activity by anti-HIV drugs

    Johanna Weiss;Johanna Rose;Caroline Henrike Storch;Nahal Ketabi-Kiyanvash

  • CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.

    Johanna Weiss;Magdalena Maria ten Hoevel;Jürgen Burhenne;Ingeborg Walter-Sack

  • Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.

    Ina Scholz;Heike Oberwittler;Klaus-Dieter Riedel;Jürgen Burhenne

  • First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B

    Antje Blank;Christoph Markert;Nicolas Hohmann;Alexandra Carls

  • Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

    Reinhard Ding;Yorki Tayrouz;Klaus‐Dieter Riedel;Jürgen Burhenne

  • Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein

    Caroline Henrike Storch;Dirk Theile;Heike Lindenmaier;Walter Emil Haefeli

  • Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study

    Kai Uwe Saum;Ben Schöttker;Ben Schöttker;Andreas D. Meid;Bernd Holleczek

  • Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

    Gerd Mikus;Verena Schöwel;Magdalena Drzewinska;Jens Rengelshausen

  • Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany.

    Cornelia Mahler;Katja Hermann;Rob Horne;Sabine Ludt

  • Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.

    Jens Rengelshausen;Maria Banfield;Klaus‐Dieter Riedel;Jürgen Burhenne

  • Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.

    Johanna Weiss;Dirk Theile;Nahal Ketabi-Kiyanvash;Heike Lindenmaier

  • Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema.

    Marc M. Berger;Christiane Hesse;Christoph Dehnert;Heike Siedler

Frequent Co-Authors

Hermann Brenner
Hermann Brenner German Cancer Research Center
Hans-Helmut König
Hans-Helmut König Universität Hamburg
Ben Schöttker
Ben Schöttker Heidelberg University
Herbert Matschinger
Herbert Matschinger Leipzig University
Stephan Rosenkranz
Stephan Rosenkranz University of Cologne
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Christel Herold-Mende
Christel Herold-Mende Heidelberg University
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Marjan van den Akker
Marjan van den Akker Goethe University Frankfurt
Stephan Urban
Stephan Urban University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open up diverse pathways for those interested in healthcare and medicine. Many students begin with programs connected to nutrition or allied health, such as earning the best online food science degree—an option for those passionate about health promotion and disease prevention through diet.

For those seeking leadership roles or management positions, pursuing accredited mha programs online enables advancement into hospital and healthcare administration. Nurses looking to further their credentials may consider bridge programs, such as an online rn to bsn no clinicals program, offering flexible coursework for working professionals.

Advanced practice nurses aiming for the highest clinical roles can enroll in the shortest msn to dnp program, accelerating their journey toward a Doctor of Nursing Practice. Each of these pathways supports varied interests—whether it’s science, direct patient care, or healthcare management—helping you tailor your career path in today’s evolving medical field.

Best Scientists Citing Walter E. Haefeli

Trending Scientists